IJR News - today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Congress
Genius — OpenServe
Trending
Blackstone backs Pfizer obesity drug with $1.5B
Health
— Nov 11, 2026
Blackstone will provide up to $1.5 billion through 2028 to help Pfizer develop berobenatide, an experimental monthly GLP-1 drug for weight management and obesity-related conditions. Pfizer retains ownership and control, while Blackstone could receive milestone payments if the drug wins U.S. approval and reaches specified sales targets.
+6
+1
2
Share
Derek Foss
Pfizer keeping ownership while Blackstone waits for approval and sales milestones seems like a fair split of risk.